Major clinical advances of depression: now and future

Depression, as one of the largest influence disorders, needs more attention on its growing patients. Medicine treatment has been seeing major for depression. As most commonly used medicine, Selective Serotonin Reuptake Inhibitors (SSRIS) increases serotonin levels to treat depression effectively, and data from clinical prove value. Furthermore, Norepinephrine (SNRIs) Monoamine Oxidase (MAOIs) by affecting at least neurotransmitter, generally is chemical in brain digestive system. Other therapies were mostly an auxiliary, such psychological therapy, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Vagus Nerve (VNS). These often work effectively stimulating neurotransmitters’ activity increasing activeness reward After new study technology production, development like ketamine can satisfy Individual Differences detailed inspection. Optogenetics auxiliary be another way increase exactness ECT VNS after solving problems actual circuits whole network. In this review, we first focus drug treatments. We then summarize current information other treatments discuss mechanisms that lead effect. Ultimately, predict future optogenetics area. The previous leads us a discover solution.